AVANOS MEDICAL, INC. Quarterly Operating Income (Loss) in USD from Q3 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Avanos Medical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q4 2024.
  • Avanos Medical, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$419M, a 3837% decline year-over-year.
  • Avanos Medical, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$396M, a 9533% decline year-over-year.
  • Avanos Medical, Inc. annual Operating Income (Loss) for 2024 was -$396M, a 9533% decline from 2023.
  • Avanos Medical, Inc. annual Operating Income (Loss) for 2023 was $4.2M, a 88.2% decline from 2022.
  • Avanos Medical, Inc. annual Operating Income (Loss) for 2022 was $35.5M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$396M -$419M -$430M -3837% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $33.5M $12M +$10.8M +900% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $22.7M $6.3M +$8.4M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $14.3M $4M +$10.1M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $4.2M $11.2M +$7.2M +180% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 -$3M $1.2M -$11.6M -90.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $8.6M -$2.1M -$12.2M -121% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $20.8M -$6.1M -$14.7M -171% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $35.5M $4M +$26.7M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-26
Q3 2022 $8.8M $12.8M +$9.4M +276% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$600K $10.1M +$17.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$18M $8.6M +$21M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$39M -$22.7M +$24.5M +51.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 -$63.5M $3.4M +$3.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$67M -$7.3M -$5.5M -306% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$61.5M -$12.4M -$13M -2167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$48.5M -$47.2M -$44M -1375% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 -$4.5M -$100K +$18M +99.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$22.5M -$1.8M +$8M +81.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$30.5M $600K +$25.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$55.7M -$3.2M +$5.1M +61.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$60.8M -$18.1M -$25.1M -359% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$35.7M -$9.8M -$18.6M -211% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$17.1M -$24.6M -$17.6M -251% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $500K -$8.3M -$5.3M -177% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $5.8M $7M +$17.4M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$11.6M $8.8M +$20.9M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$32.5M -$7M +$10.6M +60.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$43.1M -$3M +$176M +98.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$219M -$10.4M -$31.3M -150% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 -$188M -$12.1M -$29.7M -169% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$158M -$17.6M -$50.7M -153% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$107M -$179M -$441M -168% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $334M $20.9M +$482M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$148M $17.6M -$4.5M -20.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$144M $33.1M -$7.8M -19.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$136M $263M +$239M +994% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$374M -$461M -$474M -3621% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $100M $22.1M +$26.6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $73.5M $40.9M -$20.8M -33.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $94.3M $24M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $13.1M -$57.2M -81.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$4.5M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $61.7M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 $70.3M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.